Historical Stock Price
ISIS historical stock prices picture
ISIS (ISIS) has the following price history information. Looking back at ISIS historical stock prices for the last five trading days, on December 15, 2015, ISIS opened at $53.94, traded as high as $56.79 and as low as $53.57, and closed at $56.42. Trading volume was a total of 1.05M shares. On December 16, 2015, ISIS opened at $56.63, traded as high as $59.48 and as low as $56.12, and closed at $59.36. Trading volume was a total of 1.44M shares. On December 17, 2015, ISIS opened at $60.05, traded as high as $60.22 and as low as $57.53, and closed at $58.20. Trading volume was a total of 1.17M shares. On December 18, 2015, ISIS opened at $57.78, traded as high as $59.25 and as low as $57.40, and closed at $57.84. Trading volume was a total of 1.77M shares. On December 21, 2015, ISIS opened at $58.27, traded as high as $58.45 and as low as $56.70, and closed at $57.56. Trading volume was a total of 995.20K shares.

ISIS Historical Stock Prices By Date:

ISIS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into ISIS shares, starting with a $10,000 purchase of ISIS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/22/2014
End date: 12/21/2015
Start price/share: $37.00
End price/share: $57.56
Dividends collected/share: $0.00
Total return: 55.57%
Average Annual Total Return: 30.38%
Starting investment: $10,000.00
Ending investment: $15,556.54
Years: 1.67
Date Open High Low Close Volume
12/15/2015 $53.94 $56.79 $53.57 $56.42 1.05M
12/16/2015 $56.63 $59.48 $56.12 $59.36 1.44M
12/17/2015 $60.05 $60.22 $57.53 $58.20 1.17M
12/18/2015 $57.78 $59.25 $57.40 $57.84 1.77M
12/21/2015 $58.27 $58.45 $56.70 $57.56 995.20K
Isis Pharmaceuticals engages in the discovery and development of antisense drugs to treat various diseases, including severe and rare, cardiovascular, neurologic and metabolic diseases and cancer. Co. markets its key product, KYNAMRO (mipomersen sodium) injection, to patients with homozygous familial hypercholesterolemia. Co. has a pipeline of 38 drugs in development for a range of therapeutic areas. This includes TTR amyloidosis and spinal muscular atrophy drugs to treat patients with severe and rare diseases, as well as ISIS-APOCIIIRx and ISIS-FXIRx for cardiovascular diseases. Co. also works with group of companies to develop its drugs and technologies outside its primary areas of focus.
Date Close
12/15/2015$56.42
12/16/2015$59.36
12/17/2015$58.20
12/18/2015$57.84
12/21/2015$57.56
ISIS is categorized under the Healthcare sector; below are some other companies in the same sector:

ISR Historical Stock Prices
ISRG Historical Stock Prices
ITCI Historical Stock Prices
ITEK Historical Stock Prices
ITGR Historical Stock Prices
ITMN Historical Stock Prices
ITUS Historical Stock Prices
IVC Historical Stock Prices
IVTY Historical Stock Prices
JAGX Historical Stock Prices

Email EnvelopeFree ISIS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


ISIS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.